Skip to main content
. 2021 Apr 22;20:83. doi: 10.1186/s12933-021-01272-z

Fig. 8.

Fig. 8

Forest plot of meta-analysis for the comparison of adverse endocrine events between the SGLT-2i and placebo groups. a Hypoglycaemia adverse outcomes, b diabetic ketoacidosis adverse outcomes